Publikationen

325.
Wepler M, Preuss JM, Tilp C, Keck M, Blender J, Wachter U, Merz T, Vogt J, Kress S, Gröger M, Hoffmann A, Fink M, Calzia E, Burret U, Radermacher P, Tuckermann JP, Vettorazzi S. Cigarette smoke exposure reduces hemorrhagic shock induced circulatory dysfunction in mice with attenuated glucocorticoid receptor function. Frontiers in immunology. 2022; 13980707.      [DOI] 
324.
Stifel U, Wolfschmitt E, Vogt J, Wachter U, Vettorazzi S, Tews D, Hogg M, Zink F, Koll NM, Winning S, Mounier R, Chazaud B, Radermacher P, Fischer-Posovszky P, Caratti G, Tuckermann J. Glucocorticoids coordinate macrophage metabolism through the regulation of the tricarboxylic acid cycle. Molecular metabolism. 2022; 57101424.      [DOI] 
323.
Stifel U, Wolfschmitt E, Vogt J, Wachter U, Vettorazzi S, Tews D, Hogg M, Zink F, Koll NM, Winning S, Mounier R, Chazaud B, Radermacher P, Fischer-Posovszky P, Caratti G, Tuckermann J. Glucocorticoids coordinate macrophage metabolism through the regulation of the tricarboxylic acid cycle. 2022 Mä.; 57101424.      [DOI]      [Datei] 
322.
Stifel U, Wolfschmitt EM, Vogt J, Wachter U, Vettorazzi S, Tews D, Hogg M, Zink F, Koll NM, Winning S, Mounier R, Chazaud B, Radermacher P, Fischer-Posovszky P, Caratti G, Tuckermann J. Glucocorticoids coordinate macrophage metabolism through the regulation of the tricarboxylic acid cycle. Mol Metab. 2022; 57101424.      [DOI]      [Datei] 
321.
Stifel U, Wolfschmitt E, Vogt J, Wachter U, Vettorazzi S, Tews D, Hogg M, Zink F, Koll NM, Winning S, Mounier R, Chazaud B, Radermacher P, Fischer-Posovszky P, Caratti G, Tuckermann J. Glucocorticoids coordinate macrophage metabolism through the regulation of the tricarboxylic acid cycle. Molecular metabolism. 2022; 57101424.      [DOI] 
320.
Stifel U, Wolfschmitt E, Vogt J, Wachter U, Vettorazzi S, Tews D, Hogg M, Zink F, Koll NM, Winning S, Mounier R, Chazaud B, Radermacher P, Fischer-Posovszky P, Caratti G, Tuckermann J. Glucocorticoids coordinate macrophage metabolism through the regulation of the tricarboxylic acid cycle. Molecular metabolism. 2022; 57101424.      [DOI] 
319.
Stifel U, Wolfschmitt E, Vogt J, Wachter U, Vettorazzi S, Tews D, Hogg M, Zink F, Koll NM, Winning S, Mounier R, Chazaud B, Radermacher P, Fischer-Posovszky P, Caratti G, Tuckermann J. Glucocorticoids coordinate macrophage metabolism through the regulation of the tricarboxylic acid cycle.. Molecular metabolism. 2022 Mä.; 57101424.      [DOI] 
318.
Preuss JM, Burret U, Gröger M, Kress S, Scheuerle A, Möller P, Wepler M, Vettorazzi S. Impaired Glucocorticoid Receptor Signaling Aggravates Lung Injury after Hemorrhagic Shock. Cells. 2022; 11(1):112.      [DOI]      [Datei] 
317.
Nandi S, Chennappan S, Andrasch Y, Fidan M, Engler M, Ahmad M, Tuckermann JP, Zenker M, Cirstea IC. Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model. Frontiers in cell and developmental biology. 2022; 101000575.      [DOI] 
316.
Nandi S, Chennappan S, Andrasch Y, Fidan M, Engler M, Ahmad M, Tuckermann JP, Zenker M, Cirstea IC. Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model. Frontiers in cell and developmental biology. 2022; 101000575.      [DOI] 
315.
Nandi S, Chennappan S, Andrasch Y, Fidan M, Engler M, Ahmad M, Tuckermann JP, Zenker M, Cirstea IC. Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model. Frontiers in cell and developmental biology. 2022; 101000575.      [DOI] 
314.
Krüger BT, Steppe L, Vettorazzi S, Haffner-Luntzer M, Lee S, Dorn A, Ignatius A, Tuckermann J, Ahmad M. Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice. Biomedicines. 2022; 10(2):      [DOI] 
313.
Krüger BT, Steppe L, Vettorazzi S, Haffner-Luntzer M, Lee S, Dorn A, Ignatius A, Tuckermann J, Ahmad M. Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice. Biomedicines. 2022; 10(2):      [DOI] 
312.
Krüger BT, Steppe L, Vettorazzi S, Haffner-Luntzer M, Lee S, Dorn A, Ignatius A, Tuckermann J, Ahmad M. Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice. Biomedicines. 2022; 10(2):404.      [DOI]      [Datei] 
311.
Krüger BT, Steppe L, Vettorazzi S, Haffner-Luntzer M, Lee S, Dorn A, Ignatius A, Tuckermann J, Ahmad M. Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice. Biomedicines. 2022; 10(2):404.      [DOI]      [Datei] 
310.
Krüger BT, Steppe L, Vettorazzi S, Haffner-Luntzer M, Lee S, Dorn A, Ignatius A, Tuckermann J, Ahmad M. Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice. Biomedicines. 2022; 10(2):404.      [DOI]      [Datei] 
309.
Krüger BT, Steppe L, Vettorazzi S, Haffner-Luntzer M, Lee S, Dorn A, Ignatius A, Tuckermann J, Ahmad M. Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice. Biomedicines. 2022; 10(2):404.      [DOI]      [Datei] 
308.
Krüger BT, Steppe L, Vettorazzi S, Haffner-Luntzer M, Lee S, Dorn A, Ignatius A, Tuckermann J, Ahmad M. Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice. Biomedicines. 2022; 10(2):      [DOI] 
307.
Ahmad M, Krüger BT, Kroll T, Vettorazzi S, Dorn A, Mengele F, Lee S, Nandi S, Yilmaz D, Stolz M, Tangudu NK, Vázquez DC, Pachmayr J, Cirstea IC, Spasic MV, Ploubidou A, Ignatius A, Tuckermann J. Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing. Bone research. 2022; 10(1):33.      [DOI] 
306.
Ahmad M, Krüger BT, Kroll T, Vettorazzi S, Dorn AK, Mengele F, Lee S, Nandi S, Yilmaz D, Stolz M, Tangudu NK, Vazquez DC, Pachmayr J, Cirstea IC, Spasic MV, Ploubidou A, Ignatius A, Tuckermann J. Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing. Bone Research. 2022; 10(1):33.      [DOI]      [Datei] 
305.
Ahmad M, Krüger BT, Kroll T, Vettorazzi S, Dorn AK, Mengele F, Lee S, Nandi S, Yilmaz D, Stolz M, Tangudu NK, Vazquez DC, Pachmayr J, Cirstea IC, Spasic MV, Ploubidou A, Ignatius A, Tuckermann J. Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing. Bone Res. 2022; 10(1):33.      [DOI]      [Datei] 
304.
Ahmad M, Krüger BT, Kroll T, Vettorazzi S, Dorn AK, Mengele F, Lee S, Nandi S, Yilmaz D, Stolz M, Tangudu NK, Vazquez DC, Pachmayr J, Cirstea IC, Spasic MV, Ploubidou A, Ignatius A, Tuckermann J. Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing. Bone Res. 2022; 10(1):33.      [DOI]      [Datei] 
303.
Ahmad M, Krüger BT, Kroll T, Vettorazzi S, Dorn A, Mengele F, Lee S, Nandi S, Yilmaz D, Stolz M, Tangudu NK, Vázquez DC, Pachmayr J, Cirstea IC, Spasic MV, Ploubidou A, Ignatius A, Tuckermann J. Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing. Bone research. 2022; 10(1):33.      [DOI] 
302.
Ahmad M, Krüger BT, Kroll T, Vettorazzi S, Dorn A, Mengele F, Lee S, Nandi S, Yilmaz D, Stolz M, Tangudu NK, Vázquez DC, Pachmayr J, Cirstea IC, Spasic MV, Ploubidou A, Ignatius A, Tuckermann J. Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing. Bone research. 2022; 10(1):33.      [DOI] 
301.
Ahmad M, Krüger BT, Kroll T, Vettorazzi S, Dorn A, Mengele F, Lee S, Nandi S, Yilmaz D, Stolz M, Tangudu NK, Vázquez DC, Pachmayr J, Cirstea IC, Spasic MV, Ploubidou A, Ignatius A, Tuckermann J. Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing.. Bone research. 2022 Apr.; 1033.      [DOI]